Overweight, obesity and meningioma risk: A meta-analysis

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Shao, Chuan ^a   Bai, Li Ping ^b   Qi, Zhen Yu ^a   Hui, Guo Zhen ^a   Wang, Zhong ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b MAX PLANCK INSTITUTE FOR TERRESTRIAL MICROBIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BODY MASS; BODY WEIGHT; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; GENDER; GENETIC ASSOCIATION; GEOGRAPHY; HUMAN; MENINGIOMA; OBESITY; SENSITIVITY ANALYSIS;

HUMANS; MENINGIOMA; OBESITY;

EID: 84896268354     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090167     Document Type: Article

References (64)

1. Claus EB, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M, et al. (2005) Epidemiology of intracranial meningioma. Neurosurgery 57: 1088-95.
2. Ragel BT, Jensen RL (2005) Molecular genetics of meningiomas. Neurosurg Focus 19: E9.
3. Wrensch M, Minn Y, Chew T, Bondy M, Berger MS (2002) Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 4: 278-99.
4. Cowppli-Bony A, Bouvier G, Rué M, Loiseau H, Vital A, et al. (2011) Brain tumors and hormonal factors: review of the epidemiological literature. Cancer Causes Control 22: 697-714.
5. Wiemels J, Wrensch M, Claus EB (2010) Epidemiology and etiology of meningioma. J Neurooncol 99: 307-14.
6. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, et al. (2006) Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295: 1549-55.
7. Rennie KL, Jebb SA (2005) Prevalence of obesity in Great Britain. Obes Rev 6: 11-2.
8. Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4: 579-91. (Pubitemid 39025053)
9. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371: 569-78. (Pubitemid 351232031)
10. Bellur SN, Chandra V, Anderson RJ (1983) Association of meningiomas with obesity. Ann Neurol 13: 346-7.
11. Benson VS, Pirie K, Green J, Casabonne D, Beral V, et al. (2008) Lifestyle factors and primary glioma and meningioma tumours in the Million Women Study cohort. Br J Cancer 99: 185-90.
12. Claus EB, Calvocoressi L, Bondy ML, Wrensch M, Wiemels JL, et al. (2013) Exogenous hormone use, reproductive factors, and risk of intracranial meningioma in females. J Neurosurg 118: 649-56.
13. Custer B, Longstreth WT Jr, Phillips LE, Koepsell TD, Van Belle G (2006) Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study. BMC Cancer 6: 152.
14. Hemminki K, Li X, Sundquist J, Sundquist K (2011) Obesity and familial obesity and risk of cancer. Eur J Cancer Prev 20: 438-43.
15. Jhawar BS, Fuchs CS, Colditz GA, Stampfer MJ (2003) Sex steroid hormone exposures and risk for meningioma. J Neurosurg 99: 848-53. (Pubitemid 37314920)
16. Johnson DR, Olson JE, Vierkant RA, Hammack JE, Wang AH, et al. (2011) Risk factors for meningioma in postmenopausal women: results from the Iowa Women's Health Study. Neuro Oncol 13: 1011-9.
17. Jacobs DH, McFarlane MJ, Holmes FF (1986) Meningiomas and obesity reconsidered. Ann Neurol 20: 376.
18. Lee E, Grutsch J, Persky V, Glick R, Mendes J, et al. (2006) Association of meningioma with reproductive factors. Int J Cancer 119: 1152-7. (Pubitemid 44116925)
19. Michaud DS, Bové G, Gallo V, Schlehofer B, Tjønneland A, et al. (2011) Anthropometric measures, physical activity, and risk of glioma and meningioma in a large prospective cohort study. Cancer Prev Res (Phila) 4: 1385-92.
20. Schneider B, Pülhorn H, Röhrig B, Rainov NG (2005) Predisposing conditions and risk factors for development of symptomatic meningioma in adults. Cancer Detect Prev 29: 440-7. (Pubitemid 41406139)
21. Wiedmann M, Brunborg C, Lindemann K, Johannesen TB, Vatten L, et al. (2013) Body mass index and the risk of meningioma, glioma and schwannoma in a large prospective cohort study (The HUNT Study). Br J Cancer 109: 289-94.
22. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, et al. (2009) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available: http://www.ohri.ca/programs/clinical-epidemiology/ oxford.htm. Accessed 1 May 2013.
23. Greenland S (1987) Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 9: 1-30.
24. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-58. (Pubitemid 34746062)
25. Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, et al. (2011) GRADE Working Group. GRADE guidelines: 7. Rating the quality of evidence- inconsistency. J Clin Epidemiol 64: 1294-302.
26. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials. 1986 7: 177-88. (Pubitemid 17189972)
27. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-34. (Pubitemid 27387172)
28. Hamling J, Lee P, Weitkunat R, Ambühl M (2008) Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Stat Med 27: 954-70. (Pubitemid 351395458)
29. Albanes D, Taylor PR (1990) International differences in body height and weight and their relationship to cancer incidence. Nutr Cancer 14: 69-77. (Pubitemid 20202875)
30. Attner B, Landin-Olsson M, Lithman T, Noreen D, Olsson H (2012) Cancer among patients with diabetes, obesity and abnormal blood lipids: a population-based register study in Sweden. Cancer Causes Control 23: 769-77.
31. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348: 1625-38. (Pubitemid 36459468)
32. Cabaniols C, Giorgi R, Chinot O, Ferahta N, Spinelli V, et al. (2011) Links between private habits, psychological stress and brain cancer: a case-control pilot study in France. J Neurooncol 103: 307-16.
33. Helseth A, Tretli S (1989) Pre-morbid height and weight as risk factors for development of central nervous system neoplasms. Neuroepidemiology 8: 277-82. (Pubitemid 19264520)
34. Møller H, Mellemgaard A, Lindvig K, Olsen JH (1994) Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer 30: 344-50. (Pubitemid 24152476)
35. Oh SW, Yoon YS, Shin SA (2005) Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study. J Clin Oncol 23: 4742-54. (Pubitemid 46224078)
36. Pan SY, Johnson KC, Ugnat AM, Wen SW, Mao Y, et al. (2004) Association of obesity and cancer risk in Canada. Am J Epidemiol 159: 259-68. (Pubitemid 38141655)
37. Parr CL, Batty GD, Lam TH, Barzi F, Fang X, et al. (2010) Body-mass index and cancer mortality in the Asia-Pacific Cohort Studies Collaboration: pooled analyses of 424,519 participants. Lancet Oncol 11: 741-52.
38. Reeves GK, Pirie K, Beral V, Green J, Spencer E, et al. (2007) Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 335: 1134.
39. Samanic C, Gridley G, Chow WH, Lubin J, Hoover RN, et al. (2004) Obesity and cancer risk among white and black United States veterans. Cancer Causes Control 15: 35-43. (Pubitemid 38339970)
40. Samanic C, Chow WH, Gridley G, Jarvholm B, Fraumeni JF Jr (2006) Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control 17: 901-9. (Pubitemid 44078281)
41. Tulinius H, Sigfússon N, Sigvaldason H, Bjarnadóttir K, Tryggvadóttir L (1997) Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomarkers Prev 6: 863-73. (Pubitemid 27481633)
42. Wolk A, Gridley G, Svensson M, Nyrén O, McLaughlin JK, et al. (2001) A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 12: 13-21. (Pubitemid 32125897)
43. Renehan AG, Frystyk J, Flyvbjerg A (2006) Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab 17: 328-36. (Pubitemid 44397568)
44. Basen-Engquist K, Chang M (2011) Obesity and cancer risk: recent review and evidence. Curr Oncol Rep 13: 71-6.
45. Osório-Costa F, Rocha GZ, Dias MM, Carvalheira JB (2009) Epidemiological and molecular mechanisms aspects linking obesity and cancer. Arq Bras Endocrinol Metabol 53: 213-26.
46. Russo VC, Gluckman PD, Feldman EL, Werther GA (2005) The insulin-like growth factor system and its pleiotropic functions in brain. Endocr Rev 26: 916-43. (Pubitemid 41770158)
47. Joseph D'Ercole A, Ye P (2008) Expanding the mind: insulin-like growth factor I and brain development. Endocrinology 149: 5958-62.
48. Roberts DL, Dive C, Renehan AG (2010) Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med 61: 301-16.
49. Bezemer ID, Rinaldi S, Dossus L, Gils CH, Peeters PH, et al. (2005) C-peptide, IGF-I, sex-steroid hormones and adiposity: a cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control 16: 561-72. (Pubitemid 40933626)
50. Key TJ, Appleby PN, Reeves GK, Roddam A, Dorgan JF, et al. (2003) Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 95: 1218-26. (Pubitemid 37069552)
51. Derby CA, Zilber S, Brambilla D, Morales KH, McKinlay JB (2006) Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the Massachusetts Male Ageing Study. Clin Endocrinol (Oxf) 65: 125-31.
52. Oh JY, Barrett-Connor E, Wedick NM, Wingard DL, Rancho Bernardo Study (2002) Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care 25: 55-60. (Pubitemid 41070783)
53. Maor G, Segev Y and Phillip M (1999) Testosterone stimulates insulin-like growth factor-I and insulin-like growth factor-I-receptor gene expression in the mandibular condyle-a model of endochondral ossification. Endocrinology 140: 1901-10. (Pubitemid 29149264)
54. Fan ZX, Shen J, Wu YY, Yu H, Zhu Y, et al. (2013) Hormone replacement therapy and risk of meningioma in women: a meta-analysis. Cancer Causes Control 24: 1517-25.
55. Okorodudu DO, Jumean MF, Montori VM, Romero-Corral A, Somers VK, et al. (2010) Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes (Lond) 34: 791-9.
56. Smalley KJ, Knerr AN, Kendrick ZV, Colliver JA, Owen OE (1990) Reassessment of body mass indices. Am J Clin Nutr 52: 405-8.
57. Wellens RI, Roche AF, Khamis HJ, Jackson AS, Pollock ML, et al. (1990) Relationships between the Body Mass Index and body composition. Obes Res 4: 35-44.
58. Qi ZY, Shao C, Zhang X, Hui GZ, Wang Z (2013) Exogenous and Endogenous Hormones in Relation to Glioma in Women: A Meta-analysis of 11 Case-Control Studies. PLoS ONE 8: e68695.
59. Hsu DW, Efird JT, Hedley-Whyte ET (1997) Progesterone and estrogen receptors in meningiomas: prognostic considerations. J Neurosurg 86: 113-120. (Pubitemid 27009982)
60. Rubinstein AB, Loven D, Geier A, Reichenthal E, Gadoth N (1994) Hormone receptors in initially excised versus recurrent intracranial meningiomas. J Neurosurg 81: 184-187. (Pubitemid 24237995)
61. Jay JR, MacLaughlin DT, Riley KR, Martuza RL (1985) Modulation of meningioma cell growth by sex steroid hormones in vitro. J Neurosurg 62: 757-62. (Pubitemid 15091458)
62. Hatiboglu MA, Cosar M, Iplikcioglu AC, Ozcan D (2008) Sex steroid and epidermal growth factor profile of giant meningiomas associated with pregnancy. Surg Neurol 69: 356-362. (Pubitemid 351400797)
63. Rao G, Giordano SH, Liu J, McCutcheon IE (2009) The association of breast cancer and meningioma in men and women. Neurosurgery 65: 483-489.
64. Qi ZY, Shao C, Huang YL, Hui GZ, Zhou YX, et al. (2013) Reproductive and exogenous hormone factors in relation to risk of meningioma in women: a meta-analysis. PLoS One 8:e83261.